There is no single best treatment for obesity. The most effective approach depends on your starting weight, health conditions, and how your body responds over time. What the evidence does show clearly is a hierarchy of results: lifestyle changes alone produce modest weight loss, medications produce significantly more, and surgery produces the most durable results of all. Many people benefit from combining treatments, and newer medications are closing the gap between drugs and surgery in ways that weren’t possible even five years ago.
What Lifestyle Changes Can Realistically Achieve
Diet and exercise remain the foundation of every obesity treatment plan, but on their own, the results are limited. The Look AHEAD trial, one of the largest and longest studies of behavioral weight loss, followed participants for eight years. Those in an intensive program that included calorie reduction, increased physical activity, and regular counseling sessions lost an average of 4.7% of their starting body weight. About half maintained a loss of 5% or more, and roughly one in four kept off 10% or more.
Those numbers matter because even a 5% weight loss improves blood pressure, blood sugar, and cholesterol. But for someone who weighs 250 pounds, 5% is about 12 pounds, which often doesn’t match what people are hoping for. The main challenge with lifestyle-only approaches isn’t getting started. It’s that the body actively resists sustained weight loss by adjusting hunger hormones and metabolism, making long-term maintenance genuinely difficult without additional support.
How Weight Loss Medications Compare
Prescription weight loss medications are generally an option if your BMI is 30 or higher, or 27 or higher with a weight-related condition like high blood pressure or type 2 diabetes. The newest generation of injectable medications works by mimicking gut hormones that regulate appetite and blood sugar, and the results vary substantially depending on which drug you use.
At 52 weeks, medications that target a single hormone receptor (like semaglutide) produce an average weight reduction of about 7 kg, or roughly 15 pounds. Dual-action drugs like tirzepatide, which target two hormone receptors simultaneously, nearly double that to about 11 kg (24 pounds). The most striking results come from triple-action drugs still in clinical trials: retatrutide, which targets three receptor types, produced weight loss of up to 24.2% of body weight at 48 weeks in a phase 2 trial. That puts it in the range traditionally seen only with surgery.
Cost remains a real barrier. With commercial insurance and manufacturer savings programs, some patients pay as little as $25 per month for semaglutide. Without insurance coverage, self-pay pricing starts around $149 per month for lower doses, though it can be higher. Coverage varies widely between insurers, and many plans still don’t cover weight loss medications at all.
Side Effects and Tolerability
Gastrointestinal symptoms are the most common downside. In adverse event reports for semaglutide, nausea was reported by about half of users, vomiting by 30%, diarrhea by 26%, and abdominal pain by 24%. These side effects are usually worst during the initial dose-escalation period and tend to improve over several weeks. For most people they’re manageable, but they’re a meaningful quality-of-life issue for some and a reason others stop treatment.
What Happens When You Stop
This is the critical question with medications. Weight regain after stopping is substantial. In one major trial, participants regained over 40% of their lost weight within just 28 weeks of stopping semaglutide. With tirzepatide, more than 50% of lost weight returned over 52 weeks off the drug. This doesn’t mean the medications failed. It means obesity is a chronic condition, and for many people, medication needs to be ongoing to maintain results, similar to blood pressure or cholesterol drugs.
Endoscopic Procedures: A Middle Ground
Endoscopic sleeve gastroplasty sits between medications and surgery in both invasiveness and effectiveness. Performed through the mouth with no external incisions, it uses sutures to reduce the stomach’s capacity by about 70%. There’s no general anesthesia required in many cases, and hospital stays are shorter than with surgery.
Weight loss with this procedure typically ranges from 13% to 20% of total body weight at 12 months, with results holding at 16% to 20% over two to five years. That’s less than traditional surgery but more than most medications currently on the market. The safety profile is notably better than surgery: most reported side effects are mild nausea and abdominal discomfort in the first few days, and serious complications are rare. For people who don’t qualify for or don’t want surgery but need more than medication alone, it fills an important gap.
Bariatric Surgery: The Strongest Long-Term Data
Surgery remains the most effective and durable treatment for severe obesity. Current guidelines recommend bariatric surgery for anyone with a BMI over 35, regardless of other health conditions. It should also be considered at a BMI of 30 to 34.9 for people who haven’t achieved lasting results with other methods, particularly those with type 2 diabetes. For people of Asian descent, these thresholds are lower: a BMI over 27.5 qualifies for surgical consideration.
The best long-term data comes from gastric bypass. A study published in the New England Journal of Medicine tracked patients for 12 years and found they maintained an average weight loss of 35 kg (about 77 pounds) at two years, which settled to 35 kg (about 77 pounds) at 12 years. That translates to roughly 27% of their starting body weight, sustained over more than a decade. Some weight regain does occur between years two and six, but results then stabilize. Sleeve gastrectomy produces similar results, with bariatric surgery overall achieving 25% to 30% sustained weight reduction.
Surgery also has metabolic effects that go beyond weight loss. Many patients with type 2 diabetes see their blood sugar normalize within days of surgery, often before significant weight loss has occurred. Improvements in blood pressure, sleep apnea, and joint pain are common. The trade-off is that surgery is irreversible, requires general anesthesia, and carries risks including nutritional deficiencies that require lifelong vitamin supplementation.
Combining Treatments for Better Results
In practice, the most effective treatment plans layer approaches. Lifestyle changes are always part of the equation, not because they produce dramatic weight loss on their own, but because the habits support whatever other treatment you’re using. Someone on medication who also adjusts their diet and activity level will typically lose more weight and maintain it longer than someone relying on the drug alone.
Some patients start with medication and later add an endoscopic procedure if they plateau. Others use medication after bariatric surgery to prevent or reverse weight regain. There’s growing evidence that treating obesity as a chronic, multi-tool problem, rather than looking for a single solution, produces the best outcomes over a lifetime. The “best” treatment is ultimately the one that produces meaningful, sustained weight loss with side effects and lifestyle demands you can actually live with long term.